Boiron SA (LON:0DTF)

Market Cap	361.73M
Revenue (ttm)	408.41M
Net Income (ttm)	20.09M
Shares Out	n/a
EPS (ttm)	1.16
PE Ratio	18.01
Forward PE	n/a
Dividend	1.15 (4.69%)
Ex-Dividend Date	n/a

Volume	193
Average Volume	32
Open	24.65
Previous Close	24.65
Day's Range	24.50 - 24.65
52-Week Range	24.50 - 56.50
Beta	0.48
RSI	36.92
Earnings Date	Mar 20, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1932
• Employees: 2,810
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0DTF

Financial Performance

In 2023, Boiron's revenue was 493.25 million, a decrease of -7.67% compared to the previous year's 534.24 million. Earnings were 35.83 million, a decrease of -19.80%.

Financial numbers in EUR